...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: 6%

No takers?  No one knows what the 6% is?

In the AGM presentation, on slide 14, bottom right, under Zenith Epigenetics Ltd., it says

----> "6% Royalty to be paid to Zenith Capital Corp."

What is that?   I can't find it in the SEDAR docs. 

Share
New Message
Please login to post a reply